Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

被引：0
|
作者：
Wing-Lok Chan
Cheuk-Wai Choi
Ian Yu-Hong Wong
Terence Hon-Ting Tsang
Adrian Tin-Chung Lam
Rosa Pui-Ying Tse
K. K. Chan
Claudia Wong
Betty Tze-Ting Law
Emina Edith Cheung
Siu-Yin Chan
Ka-On Lam
Dora Kwong
Simon Law
机构：
[1] The University of Hong Kong,Department of Clinical Oncology, LKS Faculty of Medicine
[2] The University of Hong Kong,School of Public Health, LKS Faculty of Medicine
[3] The University of Hong Kong,Department of Surgery, LKS Faculty of Medicine
[4] The University of Hong Kong,LKS Faculty of Medicine
[5] Queen Mary Hospital,Department of Clinical Oncology
[6] Queen Mary Hospital,Department of Surgery
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：861 / 870
页数：9
相关论文
共 50 条
  • [21] Feasibility of conversion thoracoscopic esophagectomy after induction therapy for locally advanced unresectable esophageal squamous cell carcinoma
    Kubo, Kentaro
    Kanematsu, Kyohei
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Itami, Jun
    Daiko, Hiroyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (08) : 1225 - 1231
  • [22] Definitive chemoradiation in esophageal squamous-cell carcinoma: Carboplatin/paclitaxel versus cisplatin/5-FU
    Tavares, N.
    Ribeiro, M.
    Meireles, S.
    Almeida, D.
    Aguas, L.
    Costa, A.
    Fontes, P.
    Damasceno, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 12 - 12
  • [23] Predictive factors for failure of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy in esophageal squamous cell carcinoma
    Terayama, Masayoshi
    Okamura, Akihiko
    Oki, Akira
    Kuriyama, Kengo
    Takahashi, Naoki
    Tamura, Masahiro
    Kanamori, Jun
    Udagawa, Shohei
    Shimozaki, Keitaro
    Osumi, Hiroki
    Fukuoka, Shota
    Ogura, Mariko
    Chin, Keisho
    Watanabe, Masayuki
    DISEASES OF THE ESOPHAGUS, 2024, 38 (01)
  • [24] Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
    Keil, Felix
    Hartl, Maximilian
    Altorjai, Gabriela
    Berghold, Andrea
    Riedl, Regina
    Pecherstorfer, Martin
    Mayrbaeurl, Beate
    De Vries, Alexander
    Schuster, Judith
    Hackl, Jutta
    Fuereder, Thorsten
    Melchardt, Thomas
    Burian, Martin
    Greil, Richard
    EUROPEAN JOURNAL OF CANCER, 2021, 151 : 201 - 210
  • [25] MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with docetaxel, cisplatin and 5-FU (DCF) as induction therapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Even, C.
    Texier, M.
    Le Tourneau, C.
    Bahleda, R.
    Borcoman, E.
    Vinches, M.
    Toussaint, P.
    Marabelle, A.
    Breuskin, I.
    Cupissol, D.
    Fayette, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S682 - S683
  • [26] 5-FU induced encephalopathy during 5-FU containing regimen for esophageal squamous cell carcinoma.
    Kato, Ken
    Akiyoshi, Kohei
    Hokamura, Nobukazu
    Igaki, Hiroyasu
    Tachimori, Yuji
    Honma, Yoshitaka
    Iwasa, Satoru
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [27] Induction cisplatin, paclitaxel, and 5FU (PTF) before definitive local therapy for locally advanced esophageal squamous cell carcinoma (SCC)
    Fernandez, R.
    Lopez de Argumedo, G.
    Fuente, N.
    Ferreiro, J.
    Martinez, M.
    Azkona, E.
    Gutierrez, E.
    Iza, E.
    Casas, R.
    Mane, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [28] Treatment strategy involving docetaxel plus cisplatin and 5-fluorouracil followed by conversion surgery for locally advanced unresectable/borderline resectable esophageal squamous cell carcinoma
    Igaue, Shota
    Nozaki, Ryoko
    Utsunomiya, Daichi
    Kubo, Yuto
    Kubo, Kentaro
    Kurita, Daisuke
    Yamamoto, Shun
    Miyake, Mototaka
    Ishiyama, Koshiro
    Oguma, Junya
    Kato, Ken
    Daiko, Hiroyuki
    DISEASES OF THE ESOPHAGUS, 2025, 38 (01)
  • [29] TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
    Hideaki Bando
    Daisuke Kotani
    Takahiro Tsushima
    Hiroki Hara
    Shigenori Kadowaki
    Ken Kato
    Keisho Chin
    Kensei Yamaguchi
    Shun-ichiro Kageyama
    Hidehiro Hojo
    Masaki Nakamura
    Hidenobu Tachibana
    Masashi Wakabayashi
    Miki Fukutani
    Yosuke Togashi
    Nozomu Fuse
    Hiroyoshi Nishikawa
    Takashi Kojima
    BMC Cancer, 20
  • [30] Concomitant chemoradiotherapy using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with advanced sino-nasal squamous cell carcinoma.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawa, Shin-ichi
    Ikeda, Aya
    Tuchida, Kodai
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345